While the Covid-19 crisis is hopefully in definite retreat, European regulators and competition authorities are now very conscious of their vulnerability faced to global sanitary issues. European countries perceive the extent to which State intervention and State collaboration is necessary to ensure continuous and secure drugs’ supply and fostering innovation in the healthcare sector.
From genomic sequencers to online pharmacies, several competition authorities are proving very active in this field, with a clear emphasis on consumers’ welfare, identified with access to affordable medicines easily, rapidly and safely.
We will offer you an overview of the ongoing tendencies and close the Newsletter with several short highlights that may deserve a closer look in the near future.
